Complex Āyurvedic Treatment in Osteoarthritis of the Knee Compared to Standard Care. (CARAKA)
This study is currently recruiting participants.
Verified May 2013 by Charite University, Berlin, Germany
Sponsor:
Charite University, Berlin, Germany
Collaborator:
Ministry of Health & Family Welfare, India
Information provided by (Responsible Party):
Andreas Michalsen, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01225133
First received: October 6, 2010
Last updated: May 7, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of this study is to evaluate the effectiveness of a complex āyurvedic diagnosis and treatment compared to conventional standard care in patients with OA of the knee.
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoarthritis |
Other: Complex Ayurvedic Treatment Other: Conventional Care |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The CARAKA-Trial: Complex Āyurvedic Treatment in Osteoarthritis of the Knee Against Standard Care.A Multicentre, Randomized, Controlled Clinical Trial Based on Traditional Āyurveda-Diagnosis. |
Resource links provided by NLM:
Further study details as provided by Charite University, Berlin, Germany:
Primary Outcome Measures:
- Western Ontario and McMaster University Osteoarthritis Index (WOMAC) [ Time Frame: week 12 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales [ Time Frame: month 6 ] [ Designated as safety issue: No ]
- SF-36-questionnaire [ Time Frame: week 12 ] [ Designated as safety issue: No ]
- POMS-questionnaire [ Time Frame: week 12 ] [ Designated as safety issue: No ]
- Visual Analogue Scales: Pain [ Time Frame: week 12 ] [ Designated as safety issue: No ]
- Visual Analogue Scales: Sleep [ Time Frame: week 12 ] [ Designated as safety issue: No ]
- Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales [ Time Frame: month 12 ] [ Designated as safety issue: No ]
- SF-36-questionnaire [ Time Frame: month 6 ] [ Designated as safety issue: No ]
- SF-36-questionnaire [ Time Frame: month 12 ] [ Designated as safety issue: No ]
- Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales [ Time Frame: week 12 ] [ Designated as safety issue: No ]
- POMS-questionnaire [ Time Frame: month 6 ] [ Designated as safety issue: No ]
- POMS-questionnaire [ Time Frame: month 12 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 150 |
| Study Start Date: | October 2010 |
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Complex Ayurvedic Treatment
In the Āyurveda arm treatment will be individualized according to the Āyurveda diagnosis and include manual treatments, massages, dietary advice, specific consideration of selected food items, nutritional supplements, āyurvedic lifestyle and yoga posture advice and daily self-applied knee massage.
|
Other: Complex Ayurvedic Treatment
In the Āyurveda group treatment will be individualized according to the Āyurveda diagnosis and include manual treatments, massages, dietary advice, specific consideration of selected food items, nutritional supplements, āyurvedic lifestyle and yoga posture advice and daily self-applied knee massage.
Other: Conventional Care
Patients in the conventional standard care group will receive conventional standard care for OA of the Knee which includes self care advice, pain medication and intensified physiotherapy and follows the current international guidelines for OA of the knee.
|
|
Active Comparator: Conventional Care
Patients in the conventional standard care group will receive conventional standard care for OA of the Knee which includes self care advice, pain medication and intensified physiotherapy and follows the current international guidelines for OA of the knee.
|
Other: Complex Ayurvedic Treatment
In the Āyurveda group treatment will be individualized according to the Āyurveda diagnosis and include manual treatments, massages, dietary advice, specific consideration of selected food items, nutritional supplements, āyurvedic lifestyle and yoga posture advice and daily self-applied knee massage.
Other: Conventional Care
Patients in the conventional standard care group will receive conventional standard care for OA of the Knee which includes self care advice, pain medication and intensified physiotherapy and follows the current international guidelines for OA of the knee.
|
Eligibility| Ages Eligible for Study: | 40 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Male and female patients,
- Age 40-70 years,
- Prediagnosed, confirmed and documented diagnosis of OA of the knee. Diagnosis performed by a medical specialist (orthopedic surgeon, surgeon, radiologist) according to the American College of Rheumatology criteria,
- Documented radiologic changes of the knee-joint Kellgren-Lawrence criteria > or = grade 2 in conventional X-ray or MRI-scan,
- Mean average pain intensity of 40 or more on two 100 mm visual analogue scales in the 7 days before baseline assessment,
- Written informed consent.
Exclusion Criteria:
- Pain in the knee caused by oCongenital dysplasia of the affected knee oRheumatoid arthritis oAutoimmune diseases oMalignancies oStatus post Knee surgery oStatus post Arthroscopy
- Administration of chondroprotective drugs in the preceding 3 months,
- Intra-articular injection into the affected knee-joint during the preceding 3 months,
- Beginning of a systemic medication with corticosteroids within the preceding three months,
- Beginning of any new treatment for OA during the previous 4 weeks (with the exception of analgesic treatment with Paracetamol or NSAIDs),
- Pregnancy or breastfeeding,
- Acute mental disorders,
- Serious acute organic diseases,
- Serious chronic co-morbidity,
- Obesity WHO-grade II/III
- Blood coagulation disorders,
- Coagulation-inhibiting medication other than Aspirin and Clopidogrel,
- Invasive measures performed at the affected joint during the previous 12 weeks or planned within the following 12 month,
- In the process of applying for pension or disability benefits,
- Simultaneous participation in any other clinical trial,
- Participation in a clinical trial during the 6 month before inclusion into this trial,
- Missing of the written informed consent form.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01225133
Contacts
| Contact: Christian Kessler, Dr. | + 49 30 80505614 ext 614 | c.kessler@immanuel.de |
| Contact: Sabine Saalfeld | + 49 30 80505659 ext 659 | s.saalfeld@immanuel.de |
Locations
| Germany | |
| Immanuel Krankenhaus | Recruiting |
| Berlin, Germany, 14109 | |
| Contact: Christian Kessler, Dr., MA +49 30 80505 617 c.kessler@immanuel.de | |
| Principal Investigator: Andreas Michalsen, Prof. Dr. | |
| Charité Medical University Cooperation Center Sonne und Mond | Not yet recruiting |
| Berlin, Germany, 10119 | |
| Contact: Elmar Stapelfeldt, M.A. ++4915141463943 elmar.stapelfeldt@gmail.com | |
| Principal Investigator: Claudia Witt, Prof. Dr. | |
Sponsors and Collaborators
Charite University, Berlin, Germany
Ministry of Health & Family Welfare, India
Investigators
| Principal Investigator: | Andreas Michalsen, Prof. Dr. | Charité Medical University Berlin |
| Principal Investigator: | Claudia M Witt, Prof. Dr. | Charité University Medical Center Berlin |
More Information
Additional Information:
No publications provided
| Responsible Party: | Andreas Michalsen, Prof. Dr. med. Andreas Michalsen, Charite University, Berlin, Germany |
| ClinicalTrials.gov Identifier: | NCT01225133 History of Changes |
| Other Study ID Numbers: | CARAKA-1 |
| Study First Received: | October 6, 2010 |
| Last Updated: | May 7, 2013 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by Charite University, Berlin, Germany:
|
Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis |
Additional relevant MeSH terms:
|
Osteoarthritis Osteoarthritis, Knee Arthritis |
Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013